NCT03690739 2022-02-24Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian CancerAGO Research GmbHPhase 3 Terminated9 enrolled
NCT00027508 2015-02-24Ecteinascidin 743 in Treating Patients With Malignant MesotheliomaPharmaMarPhase 2 Terminated